The impact of epitranscriptomic modifications on liver disease

Keith A. Berggren, Robert E. Schwartz, Ralph Elliot Kleiner, Alexander Ploss

Research output: Contribution to journalReview articlepeer-review


RNA modifications have emerged as important mechanisms of gene regulation. Developmental, metabolic, and cell cycle regulatory processes are all affected by epitranscriptomic modifications, which control gene expression in a dynamic manner. The hepatic tissue is highly metabolically active and has an impressive ability to regenerate after injury. Cell proliferation, differentiation, and metabolism, which are all essential to the liver response to injury and regeneration, are regulated via RNA modification. Two such modifications, N6-methyladenosine (m6A)and 5-methylcytosine (m5C), have been identified as prognostic disease markers and potential therapeutic targets for liver diseases. Here, we describe progress in understanding the role of RNA modifications in liver biology and disease and discuss specific areas where unexpected results could lead to improved future understanding.

Original languageEnglish (US)
JournalTrends in Endocrinology and Metabolism
StateAccepted/In press - 2024

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


  • 5-methylcytosine
  • epitranscriptomics
  • hepatocellular carcinoma
  • liver disease
  • N6-methyladenosine
  • RNA modification
  • viral hepatitis


Dive into the research topics of 'The impact of epitranscriptomic modifications on liver disease'. Together they form a unique fingerprint.

Cite this